Possibia

1262794

Last Update Posted: 2011-09-27

Recruiting has ended

Males

accepted

20 Years-60 Years

20 Estimated Participants

No Expanded Access

Interventional Study

Accepts healthy volunteers

Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects

To evaluate the safety and tolerability of CDP6038 following single dose subcutaneous (sc) administration of CDP6038 to Japanese subjects.

To evaluate the Pharmacokinetics of CDP6038 following single dose sc administration of CDP6038 to Japanese subjects

Eligibility

Relevant conditions:

Healthy Volunteers

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Data sourced from ClinicalTrials.gov